Ownership: Chris Collins, Innate Immunotherapeutics

Chris Collins is an owner of Innate Immunotherapeutics

Title Investor
Start Date 2014-00-00
Is Current yes
Percent Stake 17%
Shares 37.9 Million
Notes Collins has disclosed a
Updated over 6 years ago

Source Links